ResearcherAcıbadem UniversityActive in the last 2 years
Saliha Elif Yıldızhan
Matched on ORCID iD 0000-0003-3489-4666; OpenAlex author ID A5011174818. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2023: 1 paper · 2024: none · 2025: 2 papers
Papers 3
- Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses. Co-author DOI 10.1016/j.ccell.2025.09.003↗
- TRANSCRIPTOMIC ANALYSIS OF THE RELATIONSHIP BETWEEN PANCREATIC DUCTAL ADENOCARCINOMA STROMAL SUBTYPES AND NEURAL INVASION Co-author DOI 10.1101/2025.01.13.632859↗
- Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion. Co-author DOI 10.1172/jci166333↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- İhsan Ekin Demir · 3 shared papers, 2023–2025 · strength 0.58
- Paper TRANSCRIPTOMIC ANALYSIS OF THE RELATIONSHIP BETWEEN PANCREATIC DUCTAL ADENOCARCINOMA STROMAL SUBTYPES AND NEURAL INVASI… DOI 10.1101/2025.01.13.632859↗
- Paper Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses. DOI 10.1016/j.ccell.2025.09.003↗
- Paper Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion. DOI 10.1172/jci166333↗
- Guralp Onur Ceyhan · 3 shared papers, 2023–2025 · strength 0.58
- Paper TRANSCRIPTOMIC ANALYSIS OF THE RELATIONSHIP BETWEEN PANCREATIC DUCTAL ADENOCARCINOMA STROMAL SUBTYPES AND NEURAL INVASI… DOI 10.1101/2025.01.13.632859↗
- Paper Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses. DOI 10.1016/j.ccell.2025.09.003↗
- Paper Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion. DOI 10.1172/jci166333↗
- Helmut Frieß · 2 shared papers, 2023–2025 · strength 0.28
- Lei Ren · 2 shared papers, 2023–2025 · strength 0.28
- Linhan Ye · 2 shared papers, 2023–2025 · strength 0.28
- Alexander Muckenhuber · 2 shared papers, 2023–2025 · strength 0.28
- Achim Krüger · 2 shared papers, 2023–2025 · strength 0.28
- Kıvanç Görgülü · 2 shared papers, 2023–2025 · strength 0.28
- Kaan Çifcibaşı · 2 shared papers, 2023–2025 · strength 0.28
- Roland Michael Schmid · 2 shared papers, 2023–2025 · strength 0.28
- Carmen Mota Reyes · 2 shared papers, 2023–2025 · strength 0.28
- Roland Rad · 2 shared papers, 2023–2025 · strength 0.28
- Hana Algül · 2 shared papers, 2023–2025 · strength 0.28
- Dieter Saur · 2 shared papers, 2023–2025 · strength 0.28
- Didem Karakaş · 1 shared paper, 2025 · strength 0.16
- Benjamin Schoeps · 1 shared paper, 2025 · strength 0.16
- Okan Safak · 1 shared paper, 2025 · strength 0.16
- Stefanie Bärthel · 1 shared paper, 2023 · strength 0.12
- Marina Lesina · 1 shared paper, 2023 · strength 0.12
- Maximilian Kießler · 1 shared paper, 2023 · strength 0.12
- Maximilian Reichert · 1 shared paper, 2023 · strength 0.12
- Xiaobo Wang · 1 shared paper, 2023 · strength 0.12
- Qiaolin Li · 1 shared paper, 2023 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.